{"id":"https://openalex.org/W2499430516","doi":"https://doi.org/10.1111/cxo.12415","title":"Influence of selective serotonin reuptake inhibitors on ocular surface","display_name":"Influence of selective serotonin reuptake inhibitors on ocular surface","publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W2499430516","doi":"https://doi.org/10.1111/cxo.12415","mag":"2499430516","pmid":"https://pubmed.ncbi.nlm.nih.gov/27476479"},"language":"en","primary_location":{"id":"doi:10.1111/cxo.12415","doi":"https://doi.org/10.1111/cxo.12415","is_oa":false,"landing_page_url":"https://doi.org/10.1111/cxo.12415","pdf_url":null,"source":{"id":"https://openalex.org/S110643388","display_name":"Clinical and Experimental Optometry","issn_l":"0816-4622","issn":["0816-4622","0817-881X","1444-0938"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Optometry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2499430516"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088281203","display_name":"Durg\u00fcl A\u00e7an","orcid":"https://orcid.org/0000-0002-9944-9902","observed_orcids":["https://orcid.org/0000-0002-9944-9902"]},"institutions":[{"id":"https://openalex.org/I4210138639","display_name":"Izmir Bozyaka E\u011fitim ve Ara\u015ft\u0131rma Hastanesi","ror":"https://ror.org/02z7qcb63","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I4210138639"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Durgul Acan","raw_affiliation_strings":["Department of Ophthalmology, Bozyaka Research and Training Hospital, Izmir, Turkey,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Bozyaka Research and Training Hospital, Izmir, Turkey,","institution_ids":["https://openalex.org/I4210138639"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011821413","display_name":"Pelin Kurtgoz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138639","display_name":"Izmir Bozyaka E\u011fitim ve Ara\u015ft\u0131rma Hastanesi","ror":"https://ror.org/02z7qcb63","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I4210138639"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Pelin Kurtgoz","raw_affiliation_strings":["Department of Psychiatry, Bozyaka Research and Training Hospital, Izmir, Turkey,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Bozyaka Research and Training Hospital, Izmir, Turkey,","institution_ids":["https://openalex.org/I4210138639"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210138639"],"apc_list":{"value":2900,"currency":"USD","value_usd":2900},"apc_paid":null,"fwci":2.4048,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.86883172,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"100","issue":"1","first_page":"83","last_page":"86"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/ocular-surface-disease","display_name":"ocular surface disease","score":0.8259999752044678},{"id":"https://openalex.org/keywords/tear-film-stability","display_name":"tear film stability","score":0.9660000205039978},{"id":"https://openalex.org/keywords/dry-eye-disease","display_name":"dry eye","score":0.6800000071525574},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.7860000133514404},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.8479999899864197},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.621999979019165},{"id":"https://openalex.org/keywords/tear-film-break-up-time","display_name":"tear film break-up time","score":0.7900000214576721},{"id":"https://openalex.org/keywords/schirmer-test","display_name":"Schirmer test","score":0.9169999957084656},{"id":"https://openalex.org/keywords/fluorescein-staining","display_name":"fluorescein staining","score":0.906000018119812},{"id":"https://openalex.org/keywords/oxford-scale","display_name":"Oxford scale","score":0.41999998688697815},{"id":"https://openalex.org/keywords/ocular-surface-disease-index","display_name":"Ocular Surface Disease Index","score":0.8539999723434448},{"id":"https://openalex.org/keywords/clinical-remission","display_name":"clinical remission","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5640480518341064},{"id":"https://openalex.org/C2910584757","wikidata":"https://www.wikidata.org/wiki/Q334477","display_name":"Serotonin Uptake Inhibitors","level":5,"score":0.5605625510215759},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5060357451438904},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4540768563747406},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.4521600604057312},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3696645498275757},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3396141231060028},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.24435949325561523},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21300554275512695},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013666","descriptor_name":"Tears","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015352","descriptor_name":"Dry Eye Syndromes","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/cxo.12415","doi":"https://doi.org/10.1111/cxo.12415","is_oa":false,"landing_page_url":"https://doi.org/10.1111/cxo.12415","pdf_url":null,"source":{"id":"https://openalex.org/S110643388","display_name":"Clinical and Experimental Optometry","issn_l":"0816-4622","issn":["0816-4622","0817-881X","1444-0938"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Optometry","raw_type":"journal-article"},{"id":"pmid:27476479","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27476479","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical & experimental optometry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W77488720","https://openalex.org/W79347276","https://openalex.org/W317245871","https://openalex.org/W1782629442","https://openalex.org/W1995945296","https://openalex.org/W2010954738","https://openalex.org/W2012429851","https://openalex.org/W2017358735","https://openalex.org/W2023351487","https://openalex.org/W2025243422","https://openalex.org/W2032106050","https://openalex.org/W2032621253","https://openalex.org/W2035105809","https://openalex.org/W2045856913","https://openalex.org/W2049299771","https://openalex.org/W2058871965","https://openalex.org/W2060590722","https://openalex.org/W2070610048","https://openalex.org/W2075150730","https://openalex.org/W2081490638","https://openalex.org/W2084315798","https://openalex.org/W2091630088","https://openalex.org/W2101372256","https://openalex.org/W2127851433","https://openalex.org/W2129689791","https://openalex.org/W2133810101","https://openalex.org/W2145074426","https://openalex.org/W2147840299","https://openalex.org/W2155951997","https://openalex.org/W2160070901","https://openalex.org/W2162443533","https://openalex.org/W2184413367","https://openalex.org/W2318855281","https://openalex.org/W2342153199","https://openalex.org/W2398070174","https://openalex.org/W2596391620","https://openalex.org/W2598546209"],"related_works":["https://openalex.org/W4229083063","https://openalex.org/W3116510164","https://openalex.org/W2915001911","https://openalex.org/W4367548265","https://openalex.org/W4366257108","https://openalex.org/W7165613307","https://openalex.org/W2967120805","https://openalex.org/W2788495733","https://openalex.org/W2980165818"],"abstract_inverted_index":{"BACKGROUND:":[0],"Antidepressant":[1],"drugs":[2],"may":[3],"have":[4],"an":[5,307],"effect":[6],"on":[7,28],"tear":[8,32,103,191,302],"film":[9,33,303],"stability.":[10,34],"This":[11],"study":[12],"aimed":[13],"to":[14,68,122,131,141,242,279,284],"determine":[15],"the":[16,90],"influence":[17],"of":[18,51,184],"selective":[19,58],"serotonin":[20,59,292],"reuptake":[21,60,293],"inhibitors,":[22,61],"which":[23],"are":[24],"mostly":[25],"prescribed":[26],"antidepressants,":[27],"ocular":[29,109,266,298],"surface":[30,110,267,299],"and":[31,40,71,77,89,96,100,128,149,175,186,197,203,221,227,248,255,274,281,305,317],"METHODS:":[35],"Thirty-six":[36],"patients":[37,56,161,168],"(Group":[38,44],"1)":[39],"36":[41],"healthy":[42],"volunteers":[43],"2)":[45],"were":[46,63,93,199,223,250,276],"enrolled.":[47],"Group":[48,126,135,147,152,158],"1":[49,107,127,148,196,215,220,247,273],"comprised":[50],"depression":[52,74,185],"and/or":[53],"anxiety":[54,79,173,187],"disorder":[55,174],"using":[57],"who":[62],"in":[64,125,134,146,151,194,218,245,271,312,319],"clinical":[65,320],"remission":[66],"according":[67,241],"psychiatric":[69],"history":[70],"questionnaires":[72],"(Hamilton":[73],"rating":[75,80],"scale":[76,244],"Hamilton":[78],"scale).":[81],"All":[82],"subjects":[83],"underwent":[84],"a":[85,182],"detailed":[86],"ophthalmological":[87],"examination":[88],"following":[91],"tests":[92],"performed:":[94],"corneal":[95],"conjunctival":[97],"fluorescein":[98],"staining":[99,240],"Oxford":[101,243],"scoring,":[102],"break-up":[104,192],"time,":[105],"Schirmer":[106,214],"test,":[108],"disease":[111,268],"index":[112,269],"score":[113],"assessment.":[114],"RESULTS:":[115],"The":[116,189,212,236,264],"mean":[117,190,213,237,265],"age":[118],"was":[119,144],"36.64":[120],"(18":[121,130],"61)":[123],"years":[124,133],"31.84":[129],"48)":[132],"2":[136,153,198,222,249,275],"(p":[137,154,209,233,261,287],">":[138,155,234],"0.05).":[139,156,235],"Male":[140],"female":[142],"ratio":[143],"0.38":[145],"0.89":[150],"In":[157],"1,":[159],"19":[160],"(52.8":[162],"per":[163,170,179],"cent)":[164,171,180],"had":[165,172,181],"depression,":[166],"16":[167],"(44.4":[169],"one":[176],"patient":[177],"(2.8":[178],"combination":[183],"disorder.":[188],"times":[193],"Groups":[195,219,246,272],"7.05":[200],"\u00b1":[201,205,225,229,253,258],"4.86":[202],"12.53":[204],"4.75":[206],"seconds,":[207],"respectively":[208,232,260,286],"<":[210,262,288],"0.001).":[211,263,289],"test":[216],"results":[217],"14.44":[224],"10.81":[226],"17.69":[228],"10.46":[230],"mm,":[231],"superficial":[238],"punctate":[239],"grade":[251,256],"0.78":[252],"0.76":[254],"0.11":[257],"0.32,":[259],"scores":[270],"32.07":[277],"(zero":[278,283],"75.00)":[280],"16.31":[282],"58.33),":[285],"CONCLUSION:":[290],"Selective":[291],"inhibitor":[294],"usage":[295],"might":[296],"affect":[297],"by":[300,314],"affecting":[301],"stability":[304],"such":[306],"association":[308],"should":[309],"be":[310],"kept":[311],"mind":[313],"both":[315],"psychiatrists":[316],"ophthalmologists":[318],"practice.":[321]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-08-23T00:00:00"}